490 related articles for article (PubMed ID: 20066418)
1. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.
Sugitani I; Toda K; Yamada K; Yamamoto N; Ikenaga M; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1222-31. PubMed ID: 20066418
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
3. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
4. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
5. An observational trial for papillary thyroid microcarcinoma in Japanese patients.
Ito Y; Miyauchi A; Inoue H; Fukushima M; Kihara M; Higashiyama T; Tomoda C; Takamura Y; Kobayashi K; Miya A
World J Surg; 2010 Jan; 34(1):28-35. PubMed ID: 20020290
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid microcarcinoma: proposal of treatment based on histological prognostic factors evaluation.
Ardito G; Avenia N; Giustozzi E; Salvatori M; Fadda G; Ardito F; Revelli L
Ann Ital Chir; 2014; 85(1):1-5. PubMed ID: 24755735
[TBL] [Abstract][Full Text] [Related]
7. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors.
Sugitani I; Fujimoto Y
Endocr J; 1999 Feb; 46(1):209-16. PubMed ID: 10426589
[TBL] [Abstract][Full Text] [Related]
9. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
[TBL] [Abstract][Full Text] [Related]
10. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected].
Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Fatani H; AlHadab A
J Otolaryngol Head Neck Surg; 2015 Dec; 44():51. PubMed ID: 26621255
[TBL] [Abstract][Full Text] [Related]
12. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
13. [Treatment strategy for patients with papillary microcarcinoma].
Sugitani I; Fujimoto Y; Yamada K
Nihon Rinsho; 2007 Nov; 65(11):2045-8. PubMed ID: 18018568
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
15. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma.
Sugitani I; Fujimoto Y; Yamada K
World J Surg; 2014 Mar; 38(3):673-8. PubMed ID: 24233662
[TBL] [Abstract][Full Text] [Related]
16. Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?
Lo CY; Chan WF; Lang BH; Lam KY; Wan KY
World J Surg; 2006 May; 30(5):759-66. PubMed ID: 16680591
[TBL] [Abstract][Full Text] [Related]
17. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature.
Garrel R; Tripodi C; Cartier C; Makeieff M; Crampette L; Guerrier B
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jun; 128(3):115-9. PubMed ID: 21333620
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
[TBL] [Abstract][Full Text] [Related]
20. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Ardito G; Revelli L; Giustozzi E; Salvatori M; Fadda G; Ardito F; Avenia N; Ferretti A; Rampin L; Chondrogiannis S; Colletti PM; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):25-8. PubMed ID: 23242040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
